What the business is, and whether it's a good one at a fair price.
Operates a food/confectionery manufacturing business with its main operations at a facility in Jangaon, Telangana, and additional facilities in Andhra Pradesh. The most clearly documented business is a jelly pouch production line, installed and commissioned in March 2026, that manufactures ₹5 Lychee and Strawberry 50ml jelly pouch packs supplied to Tata Consumer Products Limited for the domestic ready-to-eat fruit jelly/confectionery segment. Revenue from operations was Rs 2,775.44 lakhs in FY26 and Rs 820 lakhs in Q1 FY27. The company is loss-making, with a FY26 net loss of Rs 453.61 lakhs after exceptional write-offs of Rs 273.65 lakhs (bad debts and vendor advances) and an inventory write-off of Rs 241.18 lakhs attributed to operational bottlenecks. The largest cost lines are employee cost at 40.5% of revenue and other operating expenses at 49.1%, while depreciation accounts for 12.1% and capex is 10.5% of revenue. The company is proposing a name change to Pasura Industries Limited and is associated with a related party, Pasura Xpress LLP.
Measured from the filed financials, judged against its Other Financial Services peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from Arunjyoti Bio Ventures Limited's filed financials and exchange disclosures
Arunjyoti Bio Ventures Limited is a Finance company listed on BSE.
No. Over the trailing twelve months Arunjyoti Bio Ventures Limited reported a net loss of ₹4 Cr on revenue of ₹36 Cr.
Not in the latest reported year — Arunjyoti Bio Ventures Limited's dividend payout for FY26 was nil.
No. Debt stands at 0.76× equity, and it carries net debt of ₹22 Cr. That is lower than 9% of its 115 Other Financial Services peers.
On trailing P/E, Arunjyoti Bio Ventures Limited ranks 36 of 95 in Other Financial Services — cheaper than 63% of them, against an industry median of 17.9×. This is a position, not a valuation judgement.
On a typical session Arunjyoti Bio Ventures Limited moves 1.97% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by Arunjyoti Bio Ventures Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
